Overview

A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to simulate if oxycodone and naltrexone combination capsules (ALO-02) were to be tampered with by dissolving and then injecting intravenously for the purpose of getting high.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Collaborator:

Lifetree Clinical Research Center, Salt Lake City, Utah

Treatments:

Naltrexone
Oxycodone